Pricing Log in Create free account

AbbVie Inc. (ABBV) vs Eli Lilly and Company (LLY)

AbbVie Inc. and Eli Lilly and Company are both Drug Manufacturers General companies. Eli Lilly and Company is the larger, with a market value of $1.28T against $509.5B — 2.5× the size. Eli Lilly and Company trades at the lower P/E: 44.5× against 49.7×. Eli Lilly and Company grew revenue faster over the last twelve months: 45.5% against 10.7%. Eli Lilly and Company has the higher net margin (31.9% vs 15.6%) and the higher return on invested capital (26.4% vs 20.2%). Both pay a dividend; AbbVie Inc. yields more (2.40% vs 0.49%). Across the 22 metrics below, Eli Lilly and Company leads on 14 and AbbVie Inc. on 8.

Valuation

Metric ABBV LLY Drug Manufacturers General median
P/E 49.70 44.47 26.57
P/S 7.74 14.13 3.49
P/B n/m 30.35 5.20
Price to free cash flow 27.07 55.90 21.34
EV/EBITDA 20.10 34.37 14.80
EV/Sales 8.80 14.70 4.09
Earnings yield 2.01% 2.25% 2.40%
Free cash flow yield 3.69% 1.79% 4.43%

Profitability

Metric ABBV LLY Drug Manufacturers General median
Gross margin 73.72% 83.64% 73.01%
Operating margin 32.16% 40.27% 18.34%
Net margin 15.61% 31.90% 7.31%
Free cash flow margin 28.59% 22.74% 18.52%
Return on equity (288.69%) 86.02% 5.80%
Return on assets 7.32% 20.97% 2.28%
Return on invested capital 20.23% 26.42% 6.26%

Growth

Metric ABBV LLY Drug Manufacturers General median
Revenue growth (TTM) 10.68% 45.51% 6.72%
EPS growth (last fiscal year) (1.26%) 95.99% 21.81%
Revenue growth, 5-year CAGR 5.95% 21.58% 4.75%
Net income growth, 5-year CAGR (1.94%) 27.22% 0.00%

Health

Metric ABBV LLY Drug Manufacturers General median
Debt to equity (17.83) 1.17 0.63
Current ratio 0.87 1.39 1.39
Net debt to EBITDA 2.59 1.19 1.15

Dividend

Metric ABBV LLY Drug Manufacturers General median
Dividend yield 2.40% 0.49% 2.31%
Payout ratio 1.19 0.22 0.59

Size

Metric ABBV LLY Drug Manufacturers General median
Market cap 509.50b 1.28t 131.21b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack